Table 2.
Immune cell | Changing trend | Basic function | Final effect on antitumor immune |
---|---|---|---|
T cells CD8 | Decreased | CD8 + T cells clear tumor cells through perforin-granzyme and Fas-Fasl pathways. | Unfavorable |
NK cells | Decreased | NK cells can kill multiple adjacent cells if these carry with oncogenic markers. | Unfavorable |
Tregs | Increased | Tregs actively participate in the maintenance of immunological self-tolerance, thereby inducing cancer immune escape. | Unfavorable |
Macrophages M0 | Increased | TAMs can enhance tumor cell invasion and metastasis through secreting VEGF, CCL2, CXCL12, and EGF cytokines. | Unfavorable |
Macrophages M1 | Increased | M1 macrophages can mediate the differentiation of T cells and facilitate their immune functions through releasing IL-12 and IL-23. | Beneficial |
Macrophages M2 | Increased | M2 macrophages are the majority of TAMs, possessing immunosuppressive capacity and leading poor prognosis. | Unfavorable |
PR, pyroptosis-related; TIM, tumor immune microenvironment; Tregs, regulatory T cells; TAMs, tumor-associated macrophages; VEGF, vascular endothelial growth factor; CCL2, C-C motif chemokine ligand 2; CXCL12, C-X-C motif chemokine ligand 12; EGF, epidermal growth factor.